VCNX

VACCINEX, INC.

Healthcare · Biotechnology

$246.80 sample

+4.41 (+1.82%) 1D

Market cap

$264.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-23

Alerts

8

Price$246.80 +6.91% 3M daily closessample

254.92226.95

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 23SEC10-Q filed
Sep 17INSInsider buy: General Counsel
Sep 08INSInsider buy: Chief Financial Officer
Sep 01INSInsider sell: 10% owner
Aug 26INSInsider sell: Director
Aug 21INSInsider sell: 10% owner
Aug 14INSInsider sell: Chief Executive Officer
Aug 10SECForm 144 filed

Sign up to see the real VCNX record →

Company facts

SEC EDGAR registration

Name: VACCINEX, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +48sample, -100 to +100
Reporting currency: USD

Who is positioning in VCNX

sample

Insiders: 29 insider transactions over 90 days, net selling, $339.8M
Congress: No member trades over 90 days
Institutions · 13F: 7 funds hold $4.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.1B +23.7% y/y

Q4 2024Q3 2026

Inventory$4.2B +20.4% y/y

Q4 2024Q3 2026

Accounts receivable$3.0B +6.6% y/y

Q4 2024Q3 2026

Total debt$8.1B +8.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $176.0B -4.5% 3M
Sample peer B: $127.6B +6.8% 3M
Sample peer C: $44.4B -4.6% 3M
Sample peer D: $247.3B +0.6% 3M
Sample peer E: $95.3B -11.5% 3M